Journal
NUCLEIC ACIDS RESEARCH
Volume 48, Issue 20, Pages 11421-11433Publisher
OXFORD UNIV PRESS
DOI: 10.1093/nar/gkaa873
Keywords
-
Categories
Funding
- Danish Council for Independent Research, Medical Research [7016-00331B, 6110-00140B]
- Novo Nordisk Foundation (NNF) [NNF15OC0017902, NNF18OC0030274, NNF17462]
- Riisfort Foundation
- H2020 Marie Sklodowska-Curie Actions [796840]
- Marie Curie Actions (MSCA) [796840] Funding Source: Marie Curie Actions (MSCA)
Ask authors/readers for more resources
IRF3 and IRF7 are critical transcription factors in the innate immune response. Their activation is controlled by phosphorylation events, leading to the formation of homodimers that are transcriptionally active. Phosphorylation occurs when IRF3 is recruited to adaptor proteins via a positively charged surface within the regulatory domain of IRF3. This positively charged surface also plays a crucial role in forming the active homodimer by interacting with the phosphorylated sites stabilizing the homodimer. Here, we describe a distinct molecular interaction that is responsible for adaptor docking and hence phosphorylation as well as a separate interaction responsible for the formation of active homodimer. We then demonstrate that IRF7 can be activated by both MAVS and STING in a manner highly similar to that of IRF3 but with one key difference. Regulation of IRF7 appears more tightly controlled; while a single phosphorylation event is sufficient to activate IRF3, at least two phosphorylation events are required for IRF7 activation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available